Sponsor

A.O.U. Città della Salute e della Scienza

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name A.O.U. Città della Salute e della Scienza appears in 19 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials19
Recruiting shown4
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

19 shown
SILibinin in NSCLC and BC Patients With Single Brain METastasis (SILMET)NCT05689619 · lead sponsor · 2023-09-01
RECRUITING
Italian Translation and Validation of the Non-Motor Fluctuation Assessment (NoMoFA) Questionnaire: an Observational, Multicentric, Cross-sectional, 6-months Duration Study on 200 Consecutive Parkinson's Disease Patients.NCT06406374 · lead sponsor · 2023-04-26
UNKNOWN
incidenCe and predictOrs of heaRt fAiLure After Acute coronarY Syndrome: CORALYSNCT04895176 · lead sponsor · 2021-06-01
UNKNOWN
A Multidisciplinary Intervention Including a Clinical Decision Support System and an App for Drug Therapy Management in Older PatientsNCT04391218 · lead sponsor · 2021-05-01
UNKNOWN
Targeted Microwave Focal TherapyNCT04627896 · lead sponsor · 2020-11-09
COMPLETED
Telemonitoring of Patients Admitted in Hospital at Home With Acute Decompensated Heart Failure - Pilot StudyNCT04403659 · lead sponsor · 2020-06-01
UNKNOWN
Hypotonic Hyponatremia: Criteria for the Correct Classification of Its Etiology and of Patient Volume StatusNCT04402190 · lead sponsor · 2018-06-01
COMPLETED
Identification of In-hospital Patients in Need of Palliative Care Using a New Simplified Screening ToolNCT04143230 · lead sponsor · 2017-05-23
COMPLETED
Patient Reported Outcome Measurements (PROMs) Impact on Clinical Outcome in firsT Line settIng Non- Small-Cell Lung Cancer (NSCLC) According to Chemo- Immunotherapy reGimenNCT07061379 · collaborator · 2025-07-24
RECRUITING
DBS and Levodopa for Treating Freezing of Gait in Parkinson's DiseaseNCT06316232 · collaborator · 2023-10-10
RECRUITING
Loop Diuretic Therapy in Acutely Decompensated Heart FailureNCT02638142 · collaborator · 2015-12-01
RECRUITING
Clinical Application and Usability of Blood Biomarkers As Screening Tool in Alzheimer Disease: a Validation StudyNCT06699992 · collaborator · 2024-12-01
UNKNOWN
TRAnscutaneous vaGUS Nerve Stimulation in Patients With Chronic Heart FailureNCT06355388 · collaborator · 2024-05-01
NOT_YET_RECRUITING
Development of a Fluorescent Visualization System for Non-visible Lung Cancer NodulesNCT06101394 · collaborator · 2024-01-01
UNKNOWN
OPTImal PHARMacological Therapy for Patients With Heart Failure: The OPTIPHARM-HF RegistryNCT06192524 · collaborator · 2022-07-18
UNKNOWN
Rehabilitative Protocols in Progressive Multiple Sclerosis Treated with Anti CD20 Monoclonal AntibodiesNCT06894940 · collaborator · 2021-06-01
COMPLETED
Obesity Surgery During 2020 Italian PandemicNCT04480034 · collaborator · 2020-07-15
UNKNOWN
Active Surveillance or Radical Treatment for Newly Diagnosed Patients With a Localized, Low Risk, Prostate Cancer STARTNCT03348722 · collaborator · 2015-05-15
COMPLETED
T1DM Clinical Onset and Progression in Paediatric PopulationNCT03547440 · collaborator · 2015-03-18
COMPLETED

Drugs studied in this sponsor's trials

0 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing A.O.U. Città della Salute e della Scienza as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

No mapped drug interventions are published for this sponsor's trials. This does not mean the studies contain no drug interventions: some registry names have not been mapped to RxNorm.

Sponsor roles

collaborator11
lead sponsor8
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.